If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 3 of 3
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Lower Respiratory Tract PIV Infection in Immunocompromised Subjects
Protocol No
PULM-ANSUN-BIOPHARMA-FQ
Categories
NaVigation Endoscopy to Reach Indeterminate lung nodules versus Transthoracic needle Aspiration, a randomized controlled Study (VERITAS)
Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration (VERITAS)
Protocol No
PULM-MEDTRONIC-VERITASTHO19102
Categories
Reparixin 1200 mg TID as add-on to SoC to Limit Disease Progression in Hospitalised Patients With COVID-19 and Other Community-Acquired Pneumonia. A Multicentre, Randomised, Double-blinded, Placebo-controlled, Phase III Trial (REPAVID-22)
Reparixin as add-on to SOC to Limit Disease Progression in COVID-19 and Pneumonia
Protocol No
PULM-DOMPE-REPAVID-22
Categories